
- Vol 38, Issue 5
- Volume 05
Tackling the Big Issues
An introduction to the May issue of Psychiatric Times.
FROM THE CHAIRMAN
As this issue went to press, the Centers for Disease Control and Prevention reported that about
Such is the case with the
Meanwhile,
This issue also features a
As usual, this issue of Psychiatric Times™ features clinical pieces with practical guidance for supporting the patients in your care. This month’s Research Update looks at the pharmacotherapies that are most effective for schizoaffective disorder. Meanwhile, 2 articles explore the impact of psychiatric illness on the whole patient and provide suggestions to protect their well-being.
As we have learned from our tango with COVID-19, there is no challenge we cannot overcome when we work together to find and implement solutions. Our country and the field of psychiatry continue to face these and other difficult issues. Yet, with continued dedication on behalf of all of you, we are sure to realize more successes and positive outcomes in the days, months, and years to come! ❒
Mike Hennessy Sr
Chairman and Founder, MJH Life Sciences™
Parent company of PSYCHIATRIC TIMES™'
Articles in this issue
over 4 years ago
On Becoming a PMHNPover 4 years ago
Partnering for the Greater Goodover 4 years ago
Reflecting on Psychiatry’s Role in Religionover 4 years ago
Special Considerations for SGM Youth Onlineover 4 years ago
What Constitutes an SGM Community?over 4 years ago
The Mental Health of SGM Youth: Embracing Affirmationover 4 years ago
Medical Liability Costs Are on the Riseover 4 years ago
Tips for Lithium Dosing for Optimal Renal SafetyNewsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.